跳至主要内容
临床试验/IRCT20200316046795N1
IRCT20200316046795N1尚未招募3 期

Effect of oral evening primrose capsules on ripening of the cervix and progress of delivery in primiparous women

Sanandaj University of Medical Sciences0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 35 years(—)
性别
Female

入选标准

  • Willingness to participate in the study
  • Being primiparous
  • Literacy for reading and writing
  • Age 18 to 35 years old
  • Term pregnancy age (gestational age 39 weeks to 39 weeks and 6 days) based on first trimester ultrasound
  • Single-pregnancy whit cephalic presentation
  • Having a normal pelvis with a gynecologist's diagnosis
  • The estimated weight of the fetus is between 4000-2500 grams
  • Bishop score lower than or equal to 4
  • Intact membranes
  • Healthy pregnant women (without known disease, surgery or pregnancy complications such as placental abruption, placenta previa or vasoprevia , preeclampsia or no fetal anomaly)
  • No ban on the use of evening primrose oil (hemorrhagic disorders, consuming anticoagulants, individuals with a history of schizophrenia, epilepsy and consumer phenothiazine)
  • No structural cervical anomalies
  • Height above 150 cm
  • Lack of alcohol and opioids
  • Avoid using laxatives and any herbal medication prior to study

排除标准

  • Mother's unwillingness to continue cooperation in the research
  • Consumption of less than two capsules per day (problems with checklist of oral capsules)
  • Use of epidural anesthesia
  • Cesarean delivery

研究者

发起方
Sanandaj University of Medical Sciences

相似试验